A new piece in Family Practice, published by Oxford University Press, indicates that tracking symptoms affiliated with the […]

The drug has the potential to address an unmet need

The decision could see older adolescents and adults access the treatment for X-linked hypophosphataemia (XLH)

The companies have started a global pivotal Phase II/III safety and efficacy study

The move secures AZ access to the Japanese drug giant’s experimental antibody drug conjugate

Updated Date: Mon, 20 Jul 2020 00:00:00 EDT

Updated Date: Mon, 20 Jul 2020 00:00:00 EDT

Updated Date: Mon, 20 Jul 2020 00:00:00 EDT

Updated Date: Mon, 20 Jul 2020 00:00:00 EDT

Updated Date: Mon, 20 Jul 2020 00:00:00 EDT